Journal Information
Vol. 21. Issue 7.
(August - September 2025)
Share
Download PDF
More article options
Vol. 21. Issue 7.
(August - September 2025)
Brief report
Effectiveness of a checklist for the control of the disease activity in patients with axial spondyloarthritis
Eficacia de un cuadro de actuación estandarizada para el control de la actividad de la enfermedad en pacientes con espondiloartritis axial
Raquel Almodóvara,
, Elia Pérez-Fernándezb, Marta Valeroc, Virginia Villaverded, Laura Gonzáleze, Beatriz Joven Ibáñezf, Eva Tomero Murielg, Alejandro Prada Ojedah, M.a Teresa Navioi, Laura Cebrián Méndezi, Leticia Lojoi, Ramón Mazzucchellia, Pedro Zarco Montejoa
a Hospital Universitario Fundación Alcorcón, Unit of Rheumatology, Madrid, Spain
b Hospital Universitario Fundación Alcorcón, Department of Clinical Research, Madrid, Spain
c Hospital Universitario Ramón y Cajal, Department of Rheumatology, Madrid, Spain
d Hospital Universitario de Móstoles, Department of Rheumatology, Madrid, Spain
e Hospital del Tajo, Department of Rheumatology, Madrid, Spain
f Hospital Universitario 12 de Octubre, Department of Rheumatology, Madrid, Spain
g Hospital Universitario La Princesa, Department of Rheumatology, Madrid, Spain
h Hospital Universitario de Torrejón, Department of Rheumatology, Madrid, Spain
i Hospital Universitario Infanta Leonor, Department of Rheumatology, Madrid, Spain
Ver más
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (2)
Table 1. Baseline characteristics of included patients (n=108).
Tables
Table 2. Change before/after checklist implantation.
Tables
Show moreShow less
Additional material (1)
Abstract
Objectives

To assess the effectiveness of a checklist for disease activity and comorbidity control in patients with axial spondyloarthritis (axSpA).

Method

A quasi-experimental retrospective multicentre pre-post intervention study was carried out in Spain between 2016 and 2022. Improvement in disease activity and comorbidity status was determined before and after the implementation of a checklist control in patients diagnosed with axSpA. Disease activity was determined by means of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and C-reactive protein (CRP) levels. Comorbidity status was determined by analysing several risk factors (blood pressure, body weight, blood test, etc.). An analysis of variance with mixed models between pre and post collected values was performed. The change in therapeutic level and disease status (low activity, remission) was determined by means of the Mc-Nemar asymmetry test.

Results

A total of 108 patients with axSpA were included in the study. After checklist implementation, a statistically significant reduction in BASDAI of 0.44 (95%CI: 0.06–0.82, p=0.023) and a significant reduction of 3.82mg/L (p=0.001) in CRP was observed. Besides, an increase in uricemia of 0.24mg/dl was found (95%CI: 1.49–6.14, p=0.001), while no other statistically significant change in comorbidities was observed.

Conclusions

The implementation of a checklist in daily clinical practice leads to a significant improvement in the control of disease activity in patients with axSpA.

Keywords:
Axial spondyloarthritis
Checklist
Daily practice
Disease activity
Resumen
Objetivos

Evaluar la efectividad de una checklist para el control de la actividad de la enfermedad y las comorbilidades en pacientes con espondiloartritis axial (axSpA).

Métodos

Estudio multicéntrico retrospectivo pre-post intervención en España entre 2016 y 2022. La actividad de la enfermedad se determinó mediante el BASDAI y los niveles de proteína C reactiva (PCR). El estado comórbido se determinó mediante el análisis de varios factores de riesgo (presión arterial, peso corporal, analíticas, etc.). Se realizó un análisis de varianza con modelos mixtos. El cambio en el nivel terapéutico y el estado de la enfermedad (baja actividad, remisión) se determinó mediante la prueba de Mc-Nemar.

Resultados

Se incluyeron 108 pacientes. Se observó una reducción estadísticamente significativa del BASDAI de 0,44 (p=0,023) y de la PCR de 3,82mg/L (p=0,001); y un aumento de la uricemia de 0,24mg/dl (p=0,001).

Conclusiones

La implementación de una checklist en la práctica clínica diaria conlleva una mejora significativa en el control de la enfermedad en pacientes con axSpA.

Palabras clave:
Espondiloartritis axial
Lista de control
Práctica diaria
Actividad de la enfermedad

Article

These are the options to access the full texts of the publication Reumatología Clínica (English Edition)
Member
If you are member of Sociedad Española de Reumatología (SER) or the Colegio Mexicano de Reumatología (CMR):
Please go to the member area of SER or CMR and log in.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Reumatología Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
Supplemental materials
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?